Nutralife Biosciences Inc
NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutrace… Read more
Nutralife Biosciences Inc (NLBS) - Total Assets
Latest total assets as of September 2022: $6.03 Million USD
Based on the latest financial reports, Nutralife Biosciences Inc (NLBS) holds total assets worth $6.03 Million USD as of September 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nutralife Biosciences Inc - Total Assets Trend (2012–2021)
This chart illustrates how Nutralife Biosciences Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Nutralife Biosciences Inc - Asset Composition Analysis
Current Asset Composition (December 2021)
Nutralife Biosciences Inc's total assets of $6.03 Million consist of 10.7% current assets and 89.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.8% |
| Accounts Receivable | $44.20K | 0.9% |
| Inventory | $309.33K | 6.4% |
| Property, Plant & Equipment | $2.71 Million | 56.0% |
| Intangible Assets | $525.15K | 10.8% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2012–2021)
This chart illustrates how Nutralife Biosciences Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nutralife Biosciences Inc's current assets represent 10.7% of total assets in 2021, a decrease from 67.6% in 2012.
- Cash Position: Cash and equivalents constituted 2.8% of total assets in 2021, down from 58.2% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is property, plant & equipment at 56.0% of total assets.
Nutralife Biosciences Inc Competitors by Total Assets
Key competitors of Nutralife Biosciences Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Nutralife Biosciences Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Nutralife Biosciences Inc generates 0.13x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Nutralife Biosciences Inc is currently not profitable relative to its asset base.
Nutralife Biosciences Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.20 | 0.19 | 3.55 |
| Quick Ratio | 0.11 | 0.05 | 3.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.58 Million | $ -3.44 Million | $ 497.91K |
Nutralife Biosciences Inc - Advanced Valuation Insights
This section examines the relationship between Nutralife Biosciences Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 85.51 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 3.1% |
| Total Assets | $4.85 Million |
| Market Capitalization | $9.73K USD |
Valuation Analysis
Below Book Valuation: The market values Nutralife Biosciences Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Nutralife Biosciences Inc's assets grew by 3.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Nutralife Biosciences Inc (2012–2021)
The table below shows the annual total assets of Nutralife Biosciences Inc from 2012 to 2021.
| Year | Total Assets | Change |
|---|---|---|
| 2021-12-31 | $4.85 Million | +3.07% |
| 2020-12-31 | $4.71 Million | +5.40% |
| 2019-12-31 | $4.47 Million | +143.98% |
| 2018-12-31 | $1.83 Million | +91.83% |
| 2017-12-31 | $954.13K | -60.17% |
| 2016-12-31 | $2.40 Million | +8.36% |
| 2015-12-31 | $2.21 Million | +539.50% |
| 2014-12-31 | $345.69K | -46.61% |
| 2013-12-31 | $647.53K | +160.17% |
| 2012-12-31 | $248.89K | -- |